camptothecin has been researched along with sucrose in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Asher, Y; Becker, Y | 1 |
| Kessel, D; Spataro, A | 1 |
| Abelson, HT; Penman, S | 1 |
| Rajalakshmi, S; Sarma, DS | 1 |
| Butler, RN; Davidson, GP; Howarth, GS; Tooley, KL | 1 |
| Chen, LT; Dito, E; Ko, AH; Lin, YL; Ong, A; Shan, YS; Su, WC; Tempero, MA; Wang, YW; Yeh, CG | 1 |
| Saif, MW | 1 |
| Calderon, RI; Cruz, RE; Drummond, DC; Fitzgerald, JB; Hall, CP; Hindle, A; Kang, MH; Ko, W; Lee, JS; Makena, MR; Paz, N; Reynolds, CP; Song, MM; Triche, TJ; Wang, J | 1 |
| Liu, M | 1 |
| Carnevale, J; Ko, AH | 1 |
| André, T; Arbaud, C; Bachet, JB; Bennamoun, M; Bonnetain, F; Brusquant, D; Chibaudel, B; de Gramont, A; Dupuis, O; Garcia, ML; Hammel, P; Khalil, A; Larsen, AK; Louvet, C; Maindrault-Gœbel, F; Tournigand, C; Wang, YW; Yeh, CG | 1 |
| Chang, JY; Chen, LT; Chiang, NJ; Shan, YS | 1 |
2 review(s) available for camptothecin and sucrose
| Article | Year |
|---|---|
MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Camptothecin; Clinical Trials as Topic; Drug Combinations; Drug Discovery; Drug Evaluation, Preclinical; Humans; Neoplasm Staging; Pancreatic Neoplasms; Sucrose; Treatment Outcome | 2016 |
Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease-Free Survival; Drug Combinations; Fluorouracil; Humans; Leucovorin; Pancreatic Neoplasms; Sucrose; Treatment Outcome | 2016 |
3 trial(s) available for camptothecin and sucrose
| Article | Year |
|---|---|
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Camptothecin; Disease-Free Survival; Drug Combinations; Female; Humans; Irinotecan; Liposomes; Male; Middle Aged; Pancreatic Neoplasms; Salvage Therapy; Sucrose; Treatment Outcome | 2013 |
MM-398 achieves primary endpoint of overall survival in phase III study in patients with gemcitabine refractory metastatic pancreatic cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Deoxycytidine; Drug Combinations; Drug Resistance, Neoplasm; Gemcitabine; Humans; Pancreatic Neoplasms; Sucrose | 2014 |
PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Combined Modality Therapy; Drug Combinations; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Quality of Life; Retreatment; Sucrose; Treatment Outcome | 2016 |
8 other study(ies) available for camptothecin and sucrose
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vitro synthesis of DNA in nuclei isolated from herpes simplex virus-infected cells, untreated and treated with metabolic inhibitors.
Topics: Adenine Nucleotides; Animals; Anti-Bacterial Agents; Camptothecin; Cell Line; Cell Nucleus; Centrifugation, Density Gradient; Culture Media; Cytarabine; Cytosine Nucleotides; Deoxyadenosines; DNA; DNA, Viral; Guanine Nucleotides; Haplorhini; Hydroxyurea; Kidney; Magnesium; Simplexvirus; Sucrose; Thymine Nucleotides; Tritium; Virus Replication | 1975 |
The effects of camptothecin on mammalian DNA.
Topics: Animals; Camptothecin; Carbon Radioisotopes; Cell Line; Centrifugation, Density Gradient; DNA; Formamides; Hydrogen-Ion Concentration; L Cells; Leukemia, Lymphoid; Mammals; Mice; Molecular Weight; Spectrophotometry, Ultraviolet; Sucrose | 1973 |
Induction of alkali labile links in cellular DNA by camptothecin.
Topics: Alkalies; Camptothecin; Carbon Isotopes; Centrifugation, Density Gradient; DNA Repair; DNA, Neoplasm; DNA, Single-Stranded; Formamides; HeLa Cells; Hydrogen-Ion Concentration; Nucleic Acid Denaturation; Sucrose | 1973 |
Rapid repair of hepatic DNA damage induced by camptothecin in the intact rat.
Topics: Animals; Camptothecin; Centrifugation, Density Gradient; DNA Repair; DNA, Single-Stranded; Liver; Male; Rats; Sucrose; Thymidine; Tritium | 1973 |
A non-invasive method for detection of intestinal mucositis induced by different classes of chemotherapy drugs in the rat.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breath Tests; Camptothecin; Cyclophosphamide; Disease Models, Animal; DNA Topoisomerases, Type I; Doxorubicin; Etoposide; Female; Intestine, Small; Irinotecan; Mucositis; Rats; Sucrase; Sucrose; Topoisomerase I Inhibitors | 2006 |
Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in Ewing's family tumor xenografts is associated with high exposure of tumor to drug and high SLFN11 expression.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Disease Models, Animal; Drug Combinations; Female; Gene Expression; Humans; Irinotecan; Liposomes; Macrophages; Mice; Nuclear Proteins; Sarcoma, Ewing; Sucrose; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Market watch: Upcoming market catalysts in Q4 2015.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Camptothecin; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Design; Humans; Sucrose; United States; United States Food and Drug Administration | 2015 |